2021
DOI: 10.1016/j.exer.2021.108813
|View full text |Cite
|
Sign up to set email alerts
|

The potential of tear proteomics for diagnosis and management of orbital inflammatory disorders including Graves’ ophthalmopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 73 publications
0
4
0
Order By: Relevance
“…Although further research is needed, increased evidence suggests a potential role for tears as a source of biomarkers, highlighting a potential role as a diagnostic and clinical management tool [152]. Overall, these findings point to a potential role for tears as a biomarker fluid which could shape the future management of TED.…”
Section: Implications For Treatmentmentioning
confidence: 84%
“…Although further research is needed, increased evidence suggests a potential role for tears as a source of biomarkers, highlighting a potential role as a diagnostic and clinical management tool [152]. Overall, these findings point to a potential role for tears as a biomarker fluid which could shape the future management of TED.…”
Section: Implications For Treatmentmentioning
confidence: 84%
“…Tear fluid represents a promising sample type for proteomics analyses. Several studies using tear fluid have provided new insights into common ocular surface and corneal diseases, such as dry eye disease, , Sjogren’s syndrome, keratoconus, and inflammatory orbital disorders . Due to the high accessibility of tear fluid, tear proteomics represents a promising tool for molecular characterization of ocular surface disease that could lead to personalized therapies and the monitoring of therapeutic response.…”
Section: Tear Proteomicsmentioning
confidence: 99%
“…Several studies using tear fluid have provided new insights into common ocular surface and corneal diseases, such as dry eye disease, 94 , 95 Sjogren’s syndrome, 31 keratoconus, 96 and inflammatory orbital disorders. 97 Due to the high accessibility of tear fluid, tear proteomics represents a promising tool for molecular characterization of ocular surface disease that could lead to personalized therapies and the monitoring of therapeutic response. The low volume of only a few microliters represents an important challenge in tear proteomics studies, and new methods are continuously developing.…”
Section: Tear Proteomicsmentioning
confidence: 99%
“…Nevertheless, the potential significance of tear biomarkers should not be undervalued. As a non-invasive technique, tear sampling endows better advantage in providing longitudinal sampling results, which aligns well with the disease progress ( 48 ). Although specific tear biomarkers for treatment response prediction have not yet been discovered, some studies have attempted to compare tear biomarkers with CAS changes before and after treatment, suggesting its promising correlation with orbital inflammation and providing evidence for its potential application in predicting treatment response.…”
Section: Body Fluid Biomarkersmentioning
confidence: 99%